BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18656504)

  • 1. VEGF and ALS.
    Sathasivam S
    Neurosci Res; 2008 Oct; 62(2):71-7. PubMed ID: 18656504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
    Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S
    J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
    Lambrechts D; Storkebaum E; Carmeliet P
    Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J
    Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of AMPA receptors and VEGF in ALS.
    Van Damme P
    Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
    Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
    Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another angiogenic gene linked to amyotrophic lateral sclerosis.
    Lambrechts D; Lafuste P; Carmeliet P; Conway EM
    Trends Mol Med; 2006 Aug; 12(8):345-7. PubMed ID: 16843725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin changes in amyotrophic lateral sclerosis].
    Ono S
    Brain Nerve; 2007 Oct; 59(10):1099-107. PubMed ID: 17969350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
    Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
    J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of VEGF promoter polymorphisms with sporadic ALS.
    Chen W; Saeed M; Mao H; Siddique N; Dellefave L; Hung WY; Deng HX; Sufit RL; Heller SL; Haines JL; Pericak-Vance M; Siddique T
    Neurology; 2006 Aug; 67(3):508-10. PubMed ID: 16894118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons.
    Gunasekaran R; Narayani RS; Vijayalakshmi K; Alladi PA; Shobha K; Nalini A; Sathyaprabha TN; Raju TR
    Brain Res; 2009 Feb; 1255():170-9. PubMed ID: 19109933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can vitamin D delay the progression of ALS?
    Karam C; Scelsa SN
    Med Hypotheses; 2011 May; 76(5):643-5. PubMed ID: 21310542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edited GluR2, a gatekeeper for motor neurone survival?
    Buckingham SD; Kwak S; Jones AK; Blackshaw SE; Sattelle DB
    Bioessays; 2008 Nov; 30(11-12):1185-92. PubMed ID: 18937367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.
    Brockington A; Wharton SB; Fernando M; Gelsthorpe CH; Baxter L; Ince PG; Lewis CE; Shaw PJ
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):26-36. PubMed ID: 16410746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
    Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
    Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF and Neuronal Survival.
    Calvo PM; Hernández RG; Pastor AM; de la Cruz RR
    Neuroscientist; 2024 Feb; 30(1):71-86. PubMed ID: 36121037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.